Saturday 17 October 2026
Export PRTCY’s income statement to Excel — free account
PureTech Health PLC Sponsored ADR
PRTCY Healthcare Biotechnology
PureTech Health PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $4.7 million, down 3.50% from fiscal 2024.
14.56
0.34
−2.28%
Follow PRTCY
| Older periods | Jun '24 | Dec '24 | Jun '25 | Dec '25 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
3.63 | 9.19 | 8.35 | 6.41 | |
Current Ratio |
3.68 | 9.33 | 8.49 | 6.59 | |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.10 | 0.07 | 0.10 | 0.08 | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | — | |
Free Cash Flow Yield |
— | — | — | — | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(79.83) | (134.12) | (45.78) | (84.87) | |
Working Capital |
370.50 | 344.87 | 303.81 | 258.71 | |
Capital Expenditures |
0.19 | 0.24 | 0.17 | 0.26 | |
Net Current Asset Value |
235.07 | 191.55 | 160.17 | 75.98 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
5.69 | 11.94 | 4.98 | 11.13 | |
Average Payables |
32.28 | 40.93 | 25.08 | 33.65 | |
Average Assets |
701.55 | 652.64 | 623.40 | 614.34 | |
Average Common Equity |
441.12 | 477.76 | 438.96 | 381.95 |
Columns are period end dates